CIRIONI, Oscar
 Distribuzione geografica
Continente #
NA - Nord America 9.448
EU - Europa 5.670
AS - Asia 2.820
SA - Sud America 389
AF - Africa 193
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
Totale 18.539
Nazione #
US - Stati Uniti d'America 9.375
UA - Ucraina 1.191
SG - Singapore 992
RU - Federazione Russa 697
IE - Irlanda 680
SE - Svezia 658
IT - Italia 644
DE - Germania 567
TR - Turchia 560
CN - Cina 463
DK - Danimarca 435
HK - Hong Kong 425
BR - Brasile 362
FI - Finlandia 289
KR - Corea 239
FR - Francia 217
GB - Regno Unito 166
CI - Costa d'Avorio 155
IN - India 41
CA - Canada 37
IR - Iran 27
MX - Messico 27
BE - Belgio 25
AT - Austria 23
NL - Olanda 23
MA - Marocco 21
PK - Pakistan 12
PL - Polonia 12
RO - Romania 11
JP - Giappone 9
BD - Bangladesh 8
EU - Europa 8
AR - Argentina 7
AU - Australia 7
ES - Italia 6
IQ - Iraq 6
ZA - Sudafrica 6
BG - Bulgaria 5
EC - Ecuador 5
TH - Thailandia 5
UZ - Uzbekistan 5
CL - Cile 4
OM - Oman 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
EG - Egitto 3
LT - Lituania 3
NP - Nepal 3
PY - Paraguay 3
A1 - Anonimo 2
CM - Camerun 2
CO - Colombia 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TN - Tunisia 2
VN - Vietnam 2
AL - Albania 1
BB - Barbados 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 18.539
Città #
Jacksonville 1.214
Chandler 1.058
Fairfield 840
Dublin 670
Boardman 620
Ashburn 515
Singapore 498
Wilmington 494
Hong Kong 417
Woodbridge 403
Seattle 319
New York 317
Ann Arbor 313
Houston 303
Des Moines 264
Lawrence 256
Princeton 256
Cambridge 251
San Mateo 249
Moscow 206
Abidjan 155
San Diego 121
Turin 111
Beijing 110
Centro 95
Redmond 59
The Dalles 53
Los Angeles 42
London 38
Turku 38
Guangzhou 36
Shanghai 36
Munich 35
Izmir 28
Norwalk 28
Washington 28
Ancona 27
Brussels 25
Helsinki 25
São Paulo 24
Marche 23
Falls Church 22
Wuhan 22
Porto 20
Nuremberg 18
Rome 17
Mexico City 16
Dallas 15
Kilburn 15
Ottawa 15
Pune 15
Cingoli 14
Jiaxing 14
Vienna 12
Wuxi 12
Santa Clara 10
Belo Horizonte 9
Campinas 9
North Bergen 9
Atlanta 8
Dronten 8
Prescot 8
Seoul 8
Boston 7
Brasília 7
Buffalo 7
Civitanova Marche 7
Contagem 7
Genoa 7
Montreal 7
Nanjing 7
Rio de Janeiro 7
Toronto 7
Warsaw 7
Chiswick 6
Curitiba 6
Jesi 6
Milan 6
New Bedfont 6
Pergola 6
Pesaro 6
San Benedetto del Tronto 6
Shenzhen 6
Stockholm 6
Acton 5
Bangkok 5
Fayetteville 5
Manchester 5
Phoenix 5
Porto Alegre 5
Tashkent 5
Amsterdam 4
Auburn Hills 4
Boydton 4
Brooklyn 4
Campobasso 4
Chicago 4
Dalian 4
Delhi 4
Denver 4
Totale 11.104
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 270
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 218
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 192
Antimicrobial Resistance: A Challenge for the Future 182
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 148
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 139
Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium 131
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 124
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 122
Characterization of a Multiresistance Plasmid Carrying the optrA and cfr Resistance Genes From an Enterococcus faecium Clinical Isolate 122
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 120
Anticryptosporidial activity of paromomycin. 118
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 117
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 110
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 106
Antimicrobial activity of polycationic peptides 106
Tigecycline accelerates staphylococcal infected burn wound helaing through MMP-9 modlualtion 105
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 103
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 101
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 101
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 101
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 100
Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli 99
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 98
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 96
Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018 96
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 94
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 94
Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. 93
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 93
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 93
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens 92
Epidemiology and microbiology of surgical wound infections. 91
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 91
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 91
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 91
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 90
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 90
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 90
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 90
In-vitro activity of rifabutin and albendazolo singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. 89
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 88
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 87
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 87
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 87
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 87
Urinary catheters and biofilm formation 87
Review: A safety profile of dalbavancin for onand off-label utilization 86
Quorum Sensing Inhibitor FS3-coated Vascular Graft Enhances Daptomycin Efficacy in a Rat Model of Staphylococcal Biofilm Infection. 85
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 84
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 84
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 84
OpuC--an ABC transporter that is associated with Staphylococcus aureus pathogenesis. 83
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 83
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 83
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 83
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. 82
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in a animal model of ureteral stent infection. 82
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum. 82
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 82
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 82
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 82
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 81
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 81
Effect of omiganan on colonic anastomosis healing in a rat model of peritonitis 81
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 81
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 81
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 80
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 80
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 80
Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression 80
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 79
In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. 79
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 79
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 79
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. 79
Durability and tolerability of long-term nevirapine-based HAART. 78
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 78
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 78
Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA) 78
New evidence and insights on dalbavancin and wound healing in a mouse model of skin infection 78
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 77
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 77
Interindividual and intra-individual variabilities of Darunavir and Ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens. 77
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 77
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. 76
In- vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii. 76
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 76
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 76
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 76
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 75
RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus. 75
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes 75
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 75
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 75
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 75
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 75
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 75
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 75
Efficacy of LL-37 and Granulocyte-Colony Stimulating Factor in a Neutropenic Murine Sepsis due to Pseudomonas aeruginosa 74
Totale 9.414
Categoria #
all - tutte 101.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020355 0 0 0 0 0 0 0 0 0 0 0 355
2020/20213.635 186 389 497 50 395 233 372 226 367 369 378 173
2021/20222.042 132 450 13 106 33 147 92 118 142 267 133 409
2022/20233.482 349 337 256 248 267 518 7 182 891 18 277 132
2023/20241.991 366 48 134 323 349 416 34 55 22 24 26 194
2024/20253.933 551 335 250 131 156 214 423 170 899 227 419 158
Totale 18.882